A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.
Variations in lung cancer treatment may be limiting survival in England, according to a new study.
Our researcher, Professor Caroline Dive, has received a CBE in this year's New Year's Honours list. We spoke to her about her outstanding career.
Two important cancer genes cooperate to make lung cancers more aggressive in mice, according to new research.
Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.
A world-first data report could help us understand whether cancer patients are getting the most appropriate treatments for them.
From this week’s cancer news we look at how HIV research could offer clues about lung cancer and bust headlines about a radiotherapy ‘cure’ for prostate cancer.
Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.
In this week's news a drug was approved for some lung cancer patients in England, and vaping could be a big piece of the quitting smoking puzzle.
A new recommendation by NICE gives certain lung cancer patients access to the immunotherapy drug nivolumab, through the Cancer Drugs Fund.